nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—prostate cancer—urinary bladder cancer	0.727	1	CtDrD
Flutamide—CYP1B1—Doxorubicin—urinary bladder cancer	0.0296	0.354	CbGbCtD
Flutamide—CYP3A4—Thiotepa—urinary bladder cancer	0.0164	0.196	CbGbCtD
Flutamide—CYP3A5—Etoposide—urinary bladder cancer	0.0114	0.137	CbGbCtD
Flutamide—CYP1A2—Fluorouracil—urinary bladder cancer	0.0102	0.122	CbGbCtD
Flutamide—AR—scrotum—urinary bladder cancer	0.00868	0.21	CbGeAlD
Flutamide—CYP1A2—Etoposide—urinary bladder cancer	0.0085	0.102	CbGbCtD
Flutamide—CYP3A4—Etoposide—urinary bladder cancer	0.00445	0.0533	CbGbCtD
Flutamide—AR—penis—urinary bladder cancer	0.00392	0.0947	CbGeAlD
Flutamide—Nilutamide—POR—urinary bladder cancer	0.00385	1	CrCbGaD
Flutamide—CYP3A4—Doxorubicin—urinary bladder cancer	0.00304	0.0363	CbGbCtD
Flutamide—CYP2C19—urine—urinary bladder cancer	0.00241	0.0584	CbGeAlD
Flutamide—CYP1A2—urine—urinary bladder cancer	0.00197	0.0477	CbGeAlD
Flutamide—AHR—prostate gland—urinary bladder cancer	0.0019	0.0459	CbGeAlD
Flutamide—AHR—seminal vesicle—urinary bladder cancer	0.0016	0.0388	CbGeAlD
Flutamide—CYP3A4—urine—urinary bladder cancer	0.00143	0.0345	CbGeAlD
Flutamide—AHR—smooth muscle tissue—urinary bladder cancer	0.00134	0.0325	CbGeAlD
Flutamide—AHR—urethra—urinary bladder cancer	0.00127	0.0307	CbGeAlD
Flutamide—AHR—female reproductive system—urinary bladder cancer	0.00104	0.025	CbGeAlD
Flutamide—CYP1B1—prostate gland—urinary bladder cancer	0.000988	0.0239	CbGeAlD
Flutamide—AHR—vagina—urinary bladder cancer	0.000936	0.0226	CbGeAlD
Flutamide—AR—prostate gland—urinary bladder cancer	0.000935	0.0226	CbGeAlD
Flutamide—AR—seminal vesicle—urinary bladder cancer	0.000791	0.0191	CbGeAlD
Flutamide—CYP1B1—smooth muscle tissue—urinary bladder cancer	0.000699	0.0169	CbGeAlD
Flutamide—AR—epithelium—urinary bladder cancer	0.000687	0.0166	CbGeAlD
Flutamide—CYP3A5—prostate gland—urinary bladder cancer	0.000683	0.0165	CbGeAlD
Flutamide—CYP1B1—renal system—urinary bladder cancer	0.000673	0.0163	CbGeAlD
Flutamide—AR—smooth muscle tissue—urinary bladder cancer	0.000662	0.016	CbGeAlD
Flutamide—AR—renal system—urinary bladder cancer	0.000638	0.0154	CbGeAlD
Flutamide—AR—urethra—urinary bladder cancer	0.000626	0.0151	CbGeAlD
Flutamide—AHR—lymph node—urinary bladder cancer	0.000606	0.0146	CbGeAlD
Flutamide—CYP1B1—female reproductive system—urinary bladder cancer	0.000539	0.013	CbGeAlD
Flutamide—CYP1A1—epithelium—urinary bladder cancer	0.000513	0.0124	CbGeAlD
Flutamide—AR—female reproductive system—urinary bladder cancer	0.000511	0.0123	CbGeAlD
Flutamide—CYP1A2—renal system—urinary bladder cancer	0.000483	0.0117	CbGeAlD
Flutamide—CYP1A1—renal system—urinary bladder cancer	0.000476	0.0115	CbGeAlD
Flutamide—CYP1A1—urethra—urinary bladder cancer	0.000468	0.0113	CbGeAlD
Flutamide—CYP3A5—renal system—urinary bladder cancer	0.000465	0.0113	CbGeAlD
Flutamide—AR—vagina—urinary bladder cancer	0.000462	0.0112	CbGeAlD
Flutamide—CYP2C19—vagina—urinary bladder cancer	0.000428	0.0103	CbGeAlD
Flutamide—CYP1A1—female reproductive system—urinary bladder cancer	0.000381	0.00922	CbGeAlD
Flutamide—CYP3A4—renal system—urinary bladder cancer	0.000349	0.00845	CbGeAlD
Flutamide—CYP1A1—vagina—urinary bladder cancer	0.000345	0.00834	CbGeAlD
Flutamide—CYP3A5—vagina—urinary bladder cancer	0.000337	0.00815	CbGeAlD
Flutamide—CYP1B1—lymph node—urinary bladder cancer	0.000315	0.00763	CbGeAlD
Flutamide—AR—lymph node—urinary bladder cancer	0.000299	0.00722	CbGeAlD
Flutamide—CYP3A4—female reproductive system—urinary bladder cancer	0.00028	0.00676	CbGeAlD
Flutamide—CYP1A1—lymph node—urinary bladder cancer	0.000223	0.00539	CbGeAlD
Flutamide—Neoplasm—Methotrexate—urinary bladder cancer	0.00018	0.00219	CcSEcCtD
Flutamide—Bladder pain—Methotrexate—urinary bladder cancer	0.00018	0.00219	CcSEcCtD
Flutamide—Ecchymosis—Methotrexate—urinary bladder cancer	0.00018	0.00219	CcSEcCtD
Flutamide—Cystitis—Epirubicin—urinary bladder cancer	0.00018	0.00219	CcSEcCtD
Flutamide—Gynaecomastia—Methotrexate—urinary bladder cancer	0.000178	0.00217	CcSEcCtD
Flutamide—Blood urea increased—Epirubicin—urinary bladder cancer	0.000176	0.00214	CcSEcCtD
Flutamide—Hypertension—Thiotepa—urinary bladder cancer	0.000175	0.00213	CcSEcCtD
Flutamide—Pulmonary embolism—Doxorubicin—urinary bladder cancer	0.000173	0.0021	CcSEcCtD
Flutamide—Anxiety—Thiotepa—urinary bladder cancer	0.000172	0.00209	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.000171	0.00208	CcSEcCtD
Flutamide—Erythema—Gemcitabine—urinary bladder cancer	0.00017	0.00207	CcSEcCtD
Flutamide—Ecchymosis—Epirubicin—urinary bladder cancer	0.000169	0.00205	CcSEcCtD
Flutamide—Neoplasm—Epirubicin—urinary bladder cancer	0.000169	0.00205	CcSEcCtD
Flutamide—Bladder pain—Epirubicin—urinary bladder cancer	0.000169	0.00205	CcSEcCtD
Flutamide—Cystitis noninfective—Doxorubicin—urinary bladder cancer	0.000169	0.00205	CcSEcCtD
Flutamide—Erythema—Fluorouracil—urinary bladder cancer	0.000167	0.00204	CcSEcCtD
Flutamide—Cystitis—Doxorubicin—urinary bladder cancer	0.000167	0.00203	CcSEcCtD
Flutamide—Confusional state—Thiotepa—urinary bladder cancer	0.000167	0.00203	CcSEcCtD
Flutamide—Diabetes mellitus—Methotrexate—urinary bladder cancer	0.000166	0.00203	CcSEcCtD
Flutamide—Blood urea increased—Doxorubicin—urinary bladder cancer	0.000163	0.00198	CcSEcCtD
Flutamide—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.000162	0.00197	CcSEcCtD
Flutamide—Skin disorder—Thiotepa—urinary bladder cancer	0.00016	0.00195	CcSEcCtD
Flutamide—Erythema—Cisplatin—urinary bladder cancer	0.000159	0.00193	CcSEcCtD
Flutamide—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.000158	0.00192	CcSEcCtD
Flutamide—Anorexia—Thiotepa—urinary bladder cancer	0.000157	0.00192	CcSEcCtD
Flutamide—Anaemia—Gemcitabine—urinary bladder cancer	0.000157	0.00192	CcSEcCtD
Flutamide—Bladder pain—Doxorubicin—urinary bladder cancer	0.000156	0.0019	CcSEcCtD
Flutamide—Ecchymosis—Doxorubicin—urinary bladder cancer	0.000156	0.0019	CcSEcCtD
Flutamide—Neoplasm—Doxorubicin—urinary bladder cancer	0.000156	0.0019	CcSEcCtD
Flutamide—Diabetes mellitus—Epirubicin—urinary bladder cancer	0.000156	0.0019	CcSEcCtD
Flutamide—Anaemia—Fluorouracil—urinary bladder cancer	0.000155	0.00189	CcSEcCtD
Flutamide—Malaise—Gemcitabine—urinary bladder cancer	0.000154	0.00187	CcSEcCtD
Flutamide—Leukopenia—Gemcitabine—urinary bladder cancer	0.000152	0.00186	CcSEcCtD
Flutamide—Leukopenia—Fluorouracil—urinary bladder cancer	0.00015	0.00183	CcSEcCtD
Flutamide—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.000147	0.00179	CcSEcCtD
Flutamide—Hypertension—Gemcitabine—urinary bladder cancer	0.000147	0.00179	CcSEcCtD
Flutamide—Somnolence—Thiotepa—urinary bladder cancer	0.000147	0.00179	CcSEcCtD
Flutamide—Anaemia—Cisplatin—urinary bladder cancer	0.000147	0.00179	CcSEcCtD
Flutamide—Hot flush—Epirubicin—urinary bladder cancer	0.000145	0.00176	CcSEcCtD
Flutamide—Increased appetite—Epirubicin—urinary bladder cancer	0.000144	0.00175	CcSEcCtD
Flutamide—Diabetes mellitus—Doxorubicin—urinary bladder cancer	0.000144	0.00175	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.000144	0.00175	CcSEcCtD
Flutamide—Decreased appetite—Thiotepa—urinary bladder cancer	0.000144	0.00175	CcSEcCtD
Flutamide—Menopausal symptoms—Epirubicin—urinary bladder cancer	0.000143	0.00175	CcSEcCtD
Flutamide—Discomfort—Gemcitabine—urinary bladder cancer	0.000143	0.00174	CcSEcCtD
Flutamide—Malaise—Cisplatin—urinary bladder cancer	0.000143	0.00174	CcSEcCtD
Flutamide—Fatigue—Thiotepa—urinary bladder cancer	0.000142	0.00174	CcSEcCtD
Flutamide—Leukopenia—Cisplatin—urinary bladder cancer	0.000142	0.00173	CcSEcCtD
Flutamide—Dermatitis bullous—Epirubicin—urinary bladder cancer	0.000142	0.00173	CcSEcCtD
Flutamide—Constipation—Thiotepa—urinary bladder cancer	0.000141	0.00172	CcSEcCtD
Flutamide—Discomfort—Fluorouracil—urinary bladder cancer	0.000141	0.00172	CcSEcCtD
Flutamide—Oedema—Gemcitabine—urinary bladder cancer	0.000139	0.00169	CcSEcCtD
Flutamide—Confusional state—Fluorouracil—urinary bladder cancer	0.000138	0.00168	CcSEcCtD
Flutamide—Oedema—Fluorouracil—urinary bladder cancer	0.000137	0.00166	CcSEcCtD
Flutamide—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000136	0.00166	CcSEcCtD
Flutamide—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000136	0.00166	CcSEcCtD
Flutamide—Skin disorder—Gemcitabine—urinary bladder cancer	0.000135	0.00164	CcSEcCtD
Flutamide—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000135	0.00164	CcSEcCtD
Flutamide—Anxiety—Cisplatin—urinary bladder cancer	0.000135	0.00164	CcSEcCtD
Flutamide—Anaemia—Etoposide—urinary bladder cancer	0.000134	0.00164	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000134	0.00163	CcSEcCtD
Flutamide—Hot flush—Doxorubicin—urinary bladder cancer	0.000134	0.00163	CcSEcCtD
Flutamide—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000134	0.00163	CcSEcCtD
Flutamide—Discomfort—Cisplatin—urinary bladder cancer	0.000134	0.00163	CcSEcCtD
Flutamide—Increased appetite—Doxorubicin—urinary bladder cancer	0.000133	0.00162	CcSEcCtD
Flutamide—Menopausal symptoms—Doxorubicin—urinary bladder cancer	0.000133	0.00162	CcSEcCtD
Flutamide—Anorexia—Gemcitabine—urinary bladder cancer	0.000132	0.00161	CcSEcCtD
Flutamide—Malaise—Etoposide—urinary bladder cancer	0.000131	0.0016	CcSEcCtD
Flutamide—Dermatitis bullous—Doxorubicin—urinary bladder cancer	0.000131	0.0016	CcSEcCtD
Flutamide—Anorexia—Fluorouracil—urinary bladder cancer	0.00013	0.00159	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.00013	0.00159	CcSEcCtD
Flutamide—Leukopenia—Etoposide—urinary bladder cancer	0.00013	0.00159	CcSEcCtD
Flutamide—Oedema—Cisplatin—urinary bladder cancer	0.00013	0.00158	CcSEcCtD
Flutamide—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000127	0.00155	CcSEcCtD
Flutamide—Skin disorder—Cisplatin—urinary bladder cancer	0.000126	0.00153	CcSEcCtD
Flutamide—Insomnia—Gemcitabine—urinary bladder cancer	0.000126	0.00153	CcSEcCtD
Flutamide—Hypertension—Etoposide—urinary bladder cancer	0.000126	0.00153	CcSEcCtD
Flutamide—Insomnia—Fluorouracil—urinary bladder cancer	0.000124	0.00151	CcSEcCtD
Flutamide—Somnolence—Gemcitabine—urinary bladder cancer	0.000124	0.00151	CcSEcCtD
Flutamide—Anorexia—Cisplatin—urinary bladder cancer	0.000123	0.0015	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000123	0.0015	CcSEcCtD
Flutamide—Discomfort—Etoposide—urinary bladder cancer	0.000122	0.00149	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	0.000122	0.00148	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.000122	0.00148	CcSEcCtD
Flutamide—Somnolence—Fluorouracil—urinary bladder cancer	0.000121	0.00148	CcSEcCtD
Flutamide—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000121	0.00147	CcSEcCtD
Flutamide—Fatigue—Gemcitabine—urinary bladder cancer	0.00012	0.00146	CcSEcCtD
Flutamide—Confusional state—Etoposide—urinary bladder cancer	0.00012	0.00146	CcSEcCtD
Flutamide—Constipation—Gemcitabine—urinary bladder cancer	0.000119	0.00145	CcSEcCtD
Flutamide—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000119	0.00145	CcSEcCtD
Flutamide—Asthenia—Thiotepa—urinary bladder cancer	0.000119	0.00144	CcSEcCtD
Flutamide—Pruritus—Thiotepa—urinary bladder cancer	0.000117	0.00142	CcSEcCtD
Flutamide—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000116	0.00142	CcSEcCtD
Flutamide—Skin disorder—Etoposide—urinary bladder cancer	0.000115	0.0014	CcSEcCtD
Flutamide—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000115	0.0014	CcSEcCtD
Flutamide—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000115	0.0014	CcSEcCtD
Flutamide—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000114	0.00139	CcSEcCtD
Flutamide—Anorexia—Etoposide—urinary bladder cancer	0.000113	0.00138	CcSEcCtD
Flutamide—Diarrhoea—Thiotepa—urinary bladder cancer	0.000113	0.00138	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.000113	0.00137	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000113	0.00137	CcSEcCtD
Flutamide—Decreased appetite—Cisplatin—urinary bladder cancer	0.000113	0.00137	CcSEcCtD
Flutamide—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000113	0.00137	CcSEcCtD
Flutamide—Drowsiness—Methotrexate—urinary bladder cancer	0.000111	0.00136	CcSEcCtD
Flutamide—Dizziness—Thiotepa—urinary bladder cancer	0.000109	0.00133	CcSEcCtD
Flutamide—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000107	0.0013	CcSEcCtD
Flutamide—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000107	0.0013	CcSEcCtD
Flutamide—Haematuria—Methotrexate—urinary bladder cancer	0.000106	0.00129	CcSEcCtD
Flutamide—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000106	0.00129	CcSEcCtD
Flutamide—Somnolence—Etoposide—urinary bladder cancer	0.000106	0.00129	CcSEcCtD
Flutamide—Vomiting—Thiotepa—urinary bladder cancer	0.000105	0.00128	CcSEcCtD
Flutamide—Drowsiness—Epirubicin—urinary bladder cancer	0.000104	0.00127	CcSEcCtD
Flutamide—Rash—Thiotepa—urinary bladder cancer	0.000104	0.00127	CcSEcCtD
Flutamide—Dermatitis—Thiotepa—urinary bladder cancer	0.000104	0.00127	CcSEcCtD
Flutamide—Headache—Thiotepa—urinary bladder cancer	0.000103	0.00126	CcSEcCtD
Flutamide—Decreased appetite—Etoposide—urinary bladder cancer	0.000103	0.00126	CcSEcCtD
Flutamide—Fatigue—Etoposide—urinary bladder cancer	0.000102	0.00125	CcSEcCtD
Flutamide—Jaundice—Epirubicin—urinary bladder cancer	0.000102	0.00124	CcSEcCtD
Flutamide—Constipation—Etoposide—urinary bladder cancer	0.000101	0.00124	CcSEcCtD
Flutamide—Hepatitis—Methotrexate—urinary bladder cancer	0.0001	0.00122	CcSEcCtD
Flutamide—Asthenia—Gemcitabine—urinary bladder cancer	9.97e-05	0.00121	CcSEcCtD
Flutamide—Haematuria—Epirubicin—urinary bladder cancer	9.95e-05	0.00121	CcSEcCtD
Flutamide—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	9.88e-05	0.0012	CcSEcCtD
Flutamide—Pruritus—Gemcitabine—urinary bladder cancer	9.83e-05	0.0012	CcSEcCtD
Flutamide—Nausea—Thiotepa—urinary bladder cancer	9.81e-05	0.0012	CcSEcCtD
Flutamide—Feeling abnormal—Etoposide—urinary bladder cancer	9.78e-05	0.00119	CcSEcCtD
Flutamide—Hyperglycaemia—Doxorubicin—urinary bladder cancer	9.76e-05	0.00119	CcSEcCtD
Flutamide—Pruritus—Fluorouracil—urinary bladder cancer	9.67e-05	0.00118	CcSEcCtD
Flutamide—Drowsiness—Doxorubicin—urinary bladder cancer	9.65e-05	0.00118	CcSEcCtD
Flutamide—Diarrhoea—Gemcitabine—urinary bladder cancer	9.51e-05	0.00116	CcSEcCtD
Flutamide—Jaundice—Doxorubicin—urinary bladder cancer	9.41e-05	0.00115	CcSEcCtD
Flutamide—Hepatitis—Epirubicin—urinary bladder cancer	9.36e-05	0.00114	CcSEcCtD
Flutamide—Diarrhoea—Fluorouracil—urinary bladder cancer	9.35e-05	0.00114	CcSEcCtD
Flutamide—Asthenia—Cisplatin—urinary bladder cancer	9.29e-05	0.00113	CcSEcCtD
Flutamide—Oedema peripheral—Epirubicin—urinary bladder cancer	9.22e-05	0.00112	CcSEcCtD
Flutamide—Haematuria—Doxorubicin—urinary bladder cancer	9.2e-05	0.00112	CcSEcCtD
Flutamide—Dizziness—Fluorouracil—urinary bladder cancer	9.04e-05	0.0011	CcSEcCtD
Flutamide—Diarrhoea—Cisplatin—urinary bladder cancer	8.86e-05	0.00108	CcSEcCtD
Flutamide—Vomiting—Gemcitabine—urinary bladder cancer	8.84e-05	0.00108	CcSEcCtD
Flutamide—Rash—Gemcitabine—urinary bladder cancer	8.76e-05	0.00107	CcSEcCtD
Flutamide—Dermatitis—Gemcitabine—urinary bladder cancer	8.75e-05	0.00107	CcSEcCtD
Flutamide—Erythema—Methotrexate—urinary bladder cancer	8.71e-05	0.00106	CcSEcCtD
Flutamide—Headache—Gemcitabine—urinary bladder cancer	8.71e-05	0.00106	CcSEcCtD
Flutamide—Vomiting—Fluorouracil—urinary bladder cancer	8.69e-05	0.00106	CcSEcCtD
Flutamide—Hepatitis—Doxorubicin—urinary bladder cancer	8.66e-05	0.00106	CcSEcCtD
Flutamide—Rash—Fluorouracil—urinary bladder cancer	8.62e-05	0.00105	CcSEcCtD
Flutamide—Dermatitis—Fluorouracil—urinary bladder cancer	8.61e-05	0.00105	CcSEcCtD
Flutamide—Headache—Fluorouracil—urinary bladder cancer	8.56e-05	0.00104	CcSEcCtD
Flutamide—Oedema peripheral—Doxorubicin—urinary bladder cancer	8.53e-05	0.00104	CcSEcCtD
Flutamide—Asthenia—Etoposide—urinary bladder cancer	8.51e-05	0.00104	CcSEcCtD
Flutamide—Pruritus—Etoposide—urinary bladder cancer	8.4e-05	0.00102	CcSEcCtD
Flutamide—Nausea—Gemcitabine—urinary bladder cancer	8.26e-05	0.00101	CcSEcCtD
Flutamide—Vomiting—Cisplatin—urinary bladder cancer	8.24e-05	0.001	CcSEcCtD
Flutamide—Rash—Cisplatin—urinary bladder cancer	8.17e-05	0.000995	CcSEcCtD
Flutamide—Dermatitis—Cisplatin—urinary bladder cancer	8.16e-05	0.000994	CcSEcCtD
Flutamide—Erythema—Epirubicin—urinary bladder cancer	8.15e-05	0.000993	CcSEcCtD
Flutamide—Diarrhoea—Etoposide—urinary bladder cancer	8.12e-05	0.000989	CcSEcCtD
Flutamide—Nausea—Fluorouracil—urinary bladder cancer	8.12e-05	0.000989	CcSEcCtD
Flutamide—Ill-defined disorder—Methotrexate—urinary bladder cancer	8.08e-05	0.000984	CcSEcCtD
Flutamide—Anaemia—Methotrexate—urinary bladder cancer	8.05e-05	0.000981	CcSEcCtD
Flutamide—Tension—Epirubicin—urinary bladder cancer	8e-05	0.000974	CcSEcCtD
Flutamide—Nervousness—Epirubicin—urinary bladder cancer	7.92e-05	0.000964	CcSEcCtD
Flutamide—Malaise—Methotrexate—urinary bladder cancer	7.85e-05	0.000957	CcSEcCtD
Flutamide—Dizziness—Etoposide—urinary bladder cancer	7.85e-05	0.000956	CcSEcCtD
Flutamide—Leukopenia—Methotrexate—urinary bladder cancer	7.8e-05	0.00095	CcSEcCtD
Flutamide—Nausea—Cisplatin—urinary bladder cancer	7.69e-05	0.000937	CcSEcCtD
Flutamide—Ill-defined disorder—Epirubicin—urinary bladder cancer	7.56e-05	0.000921	CcSEcCtD
Flutamide—Vomiting—Etoposide—urinary bladder cancer	7.55e-05	0.000919	CcSEcCtD
Flutamide—Erythema—Doxorubicin—urinary bladder cancer	7.54e-05	0.000919	CcSEcCtD
Flutamide—Anaemia—Epirubicin—urinary bladder cancer	7.53e-05	0.000918	CcSEcCtD
Flutamide—Rash—Etoposide—urinary bladder cancer	7.48e-05	0.000911	CcSEcCtD
Flutamide—Dermatitis—Etoposide—urinary bladder cancer	7.48e-05	0.000911	CcSEcCtD
Flutamide—Headache—Etoposide—urinary bladder cancer	7.43e-05	0.000906	CcSEcCtD
Flutamide—Tension—Doxorubicin—urinary bladder cancer	7.4e-05	0.000902	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	7.36e-05	0.000897	CcSEcCtD
Flutamide—Malaise—Epirubicin—urinary bladder cancer	7.35e-05	0.000895	CcSEcCtD
Flutamide—Discomfort—Methotrexate—urinary bladder cancer	7.33e-05	0.000892	CcSEcCtD
Flutamide—Nervousness—Doxorubicin—urinary bladder cancer	7.33e-05	0.000892	CcSEcCtD
Flutamide—Leukopenia—Epirubicin—urinary bladder cancer	7.3e-05	0.000889	CcSEcCtD
Flutamide—Confusional state—Methotrexate—urinary bladder cancer	7.17e-05	0.000873	CcSEcCtD
Flutamide—Nausea—Etoposide—urinary bladder cancer	7.05e-05	0.000859	CcSEcCtD
Flutamide—Hypertension—Epirubicin—urinary bladder cancer	7.04e-05	0.000857	CcSEcCtD
Flutamide—Ill-defined disorder—Doxorubicin—urinary bladder cancer	7e-05	0.000852	CcSEcCtD
Flutamide—Anaemia—Doxorubicin—urinary bladder cancer	6.97e-05	0.000849	CcSEcCtD
Flutamide—Thrombocytopenia—Methotrexate—urinary bladder cancer	6.96e-05	0.000848	CcSEcCtD
Flutamide—Anxiety—Epirubicin—urinary bladder cancer	6.92e-05	0.000842	CcSEcCtD
Flutamide—Skin disorder—Methotrexate—urinary bladder cancer	6.9e-05	0.000841	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	6.89e-05	0.00084	CcSEcCtD
Flutamide—Discomfort—Epirubicin—urinary bladder cancer	6.86e-05	0.000835	CcSEcCtD
Flutamide—Malaise—Doxorubicin—urinary bladder cancer	6.8e-05	0.000828	CcSEcCtD
Flutamide—Anorexia—Methotrexate—urinary bladder cancer	6.78e-05	0.000825	CcSEcCtD
Flutamide—Leukopenia—Doxorubicin—urinary bladder cancer	6.75e-05	0.000822	CcSEcCtD
Flutamide—Confusional state—Epirubicin—urinary bladder cancer	6.71e-05	0.000817	CcSEcCtD
Flutamide—Oedema—Epirubicin—urinary bladder cancer	6.65e-05	0.00081	CcSEcCtD
Flutamide—Thrombocytopenia—Epirubicin—urinary bladder cancer	6.51e-05	0.000793	CcSEcCtD
Flutamide—Hypertension—Doxorubicin—urinary bladder cancer	6.51e-05	0.000793	CcSEcCtD
Flutamide—Skin disorder—Epirubicin—urinary bladder cancer	6.46e-05	0.000787	CcSEcCtD
Flutamide—Insomnia—Methotrexate—urinary bladder cancer	6.43e-05	0.000783	CcSEcCtD
Flutamide—Anxiety—Doxorubicin—urinary bladder cancer	6.4e-05	0.000779	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	6.38e-05	0.000777	CcSEcCtD
Flutamide—Discomfort—Doxorubicin—urinary bladder cancer	6.34e-05	0.000773	CcSEcCtD
Flutamide—Anorexia—Epirubicin—urinary bladder cancer	6.34e-05	0.000772	CcSEcCtD
Flutamide—Somnolence—Methotrexate—urinary bladder cancer	6.32e-05	0.00077	CcSEcCtD
Flutamide—Confusional state—Doxorubicin—urinary bladder cancer	6.21e-05	0.000756	CcSEcCtD
Flutamide—Decreased appetite—Methotrexate—urinary bladder cancer	6.18e-05	0.000753	CcSEcCtD
Flutamide—Oedema—Doxorubicin—urinary bladder cancer	6.16e-05	0.00075	CcSEcCtD
Flutamide—Fatigue—Methotrexate—urinary bladder cancer	6.13e-05	0.000747	CcSEcCtD
Flutamide—Thrombocytopenia—Doxorubicin—urinary bladder cancer	6.03e-05	0.000734	CcSEcCtD
Flutamide—Insomnia—Epirubicin—urinary bladder cancer	6.02e-05	0.000733	CcSEcCtD
Flutamide—Skin disorder—Doxorubicin—urinary bladder cancer	5.98e-05	0.000728	CcSEcCtD
Flutamide—Somnolence—Epirubicin—urinary bladder cancer	5.91e-05	0.00072	CcSEcCtD
Flutamide—Anorexia—Doxorubicin—urinary bladder cancer	5.87e-05	0.000715	CcSEcCtD
Flutamide—Feeling abnormal—Methotrexate—urinary bladder cancer	5.86e-05	0.000714	CcSEcCtD
Flutamide—Decreased appetite—Epirubicin—urinary bladder cancer	5.78e-05	0.000704	CcSEcCtD
Flutamide—Fatigue—Epirubicin—urinary bladder cancer	5.74e-05	0.000699	CcSEcCtD
Flutamide—Constipation—Epirubicin—urinary bladder cancer	5.69e-05	0.000693	CcSEcCtD
Flutamide—Insomnia—Doxorubicin—urinary bladder cancer	5.57e-05	0.000678	CcSEcCtD
Flutamide—Feeling abnormal—Epirubicin—urinary bladder cancer	5.48e-05	0.000668	CcSEcCtD
Flutamide—Somnolence—Doxorubicin—urinary bladder cancer	5.47e-05	0.000667	CcSEcCtD
Flutamide—Decreased appetite—Doxorubicin—urinary bladder cancer	5.35e-05	0.000652	CcSEcCtD
Flutamide—Fatigue—Doxorubicin—urinary bladder cancer	5.31e-05	0.000646	CcSEcCtD
Flutamide—Constipation—Doxorubicin—urinary bladder cancer	5.26e-05	0.000641	CcSEcCtD
Flutamide—Asthenia—Methotrexate—urinary bladder cancer	5.1e-05	0.000621	CcSEcCtD
Flutamide—Feeling abnormal—Doxorubicin—urinary bladder cancer	5.07e-05	0.000618	CcSEcCtD
Flutamide—Pruritus—Methotrexate—urinary bladder cancer	5.03e-05	0.000613	CcSEcCtD
Flutamide—Diarrhoea—Methotrexate—urinary bladder cancer	4.86e-05	0.000592	CcSEcCtD
Flutamide—Asthenia—Epirubicin—urinary bladder cancer	4.77e-05	0.000581	CcSEcCtD
Flutamide—Pruritus—Epirubicin—urinary bladder cancer	4.71e-05	0.000573	CcSEcCtD
Flutamide—Dizziness—Methotrexate—urinary bladder cancer	4.7e-05	0.000573	CcSEcCtD
Flutamide—Diarrhoea—Epirubicin—urinary bladder cancer	4.55e-05	0.000554	CcSEcCtD
Flutamide—Vomiting—Methotrexate—urinary bladder cancer	4.52e-05	0.000551	CcSEcCtD
Flutamide—Rash—Methotrexate—urinary bladder cancer	4.48e-05	0.000546	CcSEcCtD
Flutamide—Dermatitis—Methotrexate—urinary bladder cancer	4.48e-05	0.000545	CcSEcCtD
Flutamide—Headache—Methotrexate—urinary bladder cancer	4.45e-05	0.000542	CcSEcCtD
Flutamide—Asthenia—Doxorubicin—urinary bladder cancer	4.42e-05	0.000538	CcSEcCtD
Flutamide—Dizziness—Epirubicin—urinary bladder cancer	4.4e-05	0.000536	CcSEcCtD
Flutamide—Pruritus—Doxorubicin—urinary bladder cancer	4.35e-05	0.00053	CcSEcCtD
Flutamide—Vomiting—Epirubicin—urinary bladder cancer	4.23e-05	0.000515	CcSEcCtD
Flutamide—Nausea—Methotrexate—urinary bladder cancer	4.22e-05	0.000514	CcSEcCtD
Flutamide—Diarrhoea—Doxorubicin—urinary bladder cancer	4.21e-05	0.000513	CcSEcCtD
Flutamide—Rash—Epirubicin—urinary bladder cancer	4.19e-05	0.000511	CcSEcCtD
Flutamide—Dermatitis—Epirubicin—urinary bladder cancer	4.19e-05	0.00051	CcSEcCtD
Flutamide—Headache—Epirubicin—urinary bladder cancer	4.17e-05	0.000508	CcSEcCtD
Flutamide—Dizziness—Doxorubicin—urinary bladder cancer	4.07e-05	0.000496	CcSEcCtD
Flutamide—Nausea—Epirubicin—urinary bladder cancer	3.95e-05	0.000481	CcSEcCtD
Flutamide—Vomiting—Doxorubicin—urinary bladder cancer	3.91e-05	0.000477	CcSEcCtD
Flutamide—Rash—Doxorubicin—urinary bladder cancer	3.88e-05	0.000473	CcSEcCtD
Flutamide—Dermatitis—Doxorubicin—urinary bladder cancer	3.88e-05	0.000472	CcSEcCtD
Flutamide—Headache—Doxorubicin—urinary bladder cancer	3.86e-05	0.00047	CcSEcCtD
Flutamide—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	3.66e-05	0.000586	CbGpPWpGaD
Flutamide—Nausea—Doxorubicin—urinary bladder cancer	3.66e-05	0.000445	CcSEcCtD
Flutamide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—urinary bladder cancer	3.65e-05	0.000585	CbGpPWpGaD
Flutamide—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—urinary bladder cancer	3.65e-05	0.000585	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	3.62e-05	0.000581	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	3.62e-05	0.000581	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—UGT2B7—urinary bladder cancer	3.55e-05	0.00057	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	3.49e-05	0.00056	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.48e-05	0.000557	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	3.42e-05	0.000548	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—NCOR1—urinary bladder cancer	3.39e-05	0.000543	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	3.37e-05	0.000541	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	3.36e-05	0.000539	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.36e-05	0.000539	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.35e-05	0.000538	CbGpPWpGaD
Flutamide—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	3.33e-05	0.000533	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	3.29e-05	0.000528	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	3.25e-05	0.000521	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	3.25e-05	0.000521	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CYP4B1—urinary bladder cancer	3.2e-05	0.000513	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.2e-05	0.000513	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	3.16e-05	0.000507	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	3.16e-05	0.000507	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.11e-05	0.000499	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	3.11e-05	0.000498	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	3.1e-05	0.000497	CbGpPWpGaD
Flutamide—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	3.06e-05	0.00049	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	3.05e-05	0.00049	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—SLC19A1—urinary bladder cancer	3.02e-05	0.000485	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	3.02e-05	0.000484	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PRSS3—urinary bladder cancer	2.94e-05	0.000472	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	2.92e-05	0.000469	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	2.83e-05	0.000454	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	2.82e-05	0.000452	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.79e-05	0.000447	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	2.77e-05	0.000444	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	2.77e-05	0.000444	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	2.76e-05	0.000443	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.73e-05	0.000437	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	2.67e-05	0.000428	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—ESR1—urinary bladder cancer	2.66e-05	0.000427	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	2.64e-05	0.000423	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	2.64e-05	0.000423	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	2.63e-05	0.000421	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	2.62e-05	0.00042	CbGpPWpGaD
Flutamide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—urinary bladder cancer	2.62e-05	0.00042	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.6e-05	0.000416	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	2.59e-05	0.000415	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.58e-05	0.000413	CbGpPWpGaD
Flutamide—CYP1A1—PPARA activates gene expression—EP300—urinary bladder cancer	2.54e-05	0.000407	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	2.53e-05	0.000406	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NAT1—urinary bladder cancer	2.53e-05	0.000406	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTZ1—urinary bladder cancer	2.52e-05	0.000405	CbGpPWpGaD
Flutamide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—urinary bladder cancer	2.51e-05	0.000403	CbGpPWpGaD
Flutamide—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—urinary bladder cancer	2.48e-05	0.000398	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—PPARG—urinary bladder cancer	2.43e-05	0.000389	CbGpPWpGaD
Flutamide—AR—Gene Expression—SMC1A—urinary bladder cancer	2.43e-05	0.000389	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	2.41e-05	0.000387	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTO2—urinary bladder cancer	2.39e-05	0.000384	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NAT1—urinary bladder cancer	2.39e-05	0.000384	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	2.38e-05	0.000382	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.36e-05	0.000379	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—TYMP—urinary bladder cancer	2.35e-05	0.000377	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	2.35e-05	0.000377	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—CREBBP—urinary bladder cancer	2.33e-05	0.000374	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	2.32e-05	0.000371	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.29e-05	0.000367	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.26e-05	0.000363	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	2.23e-05	0.000357	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—UGT2B7—urinary bladder cancer	2.19e-05	0.000351	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—NAT2—urinary bladder cancer	2.13e-05	0.000341	CbGpPWpGaD
Flutamide—AR—Gene Expression—ESR2—urinary bladder cancer	2.11e-05	0.000339	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	2.09e-05	0.000334	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	2.07e-05	0.000331	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	2.03e-05	0.000325	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	2e-05	0.000321	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP4B1—urinary bladder cancer	1.97e-05	0.000316	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	1.97e-05	0.000316	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	1.96e-05	0.000314	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NAT1—urinary bladder cancer	1.96e-05	0.000314	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	1.93e-05	0.000309	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	1.92e-05	0.000308	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	1.86e-05	0.000299	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—SLC19A1—urinary bladder cancer	1.86e-05	0.000298	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—RRM2—urinary bladder cancer	1.84e-05	0.000295	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	1.84e-05	0.000295	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PRSS3—urinary bladder cancer	1.81e-05	0.000291	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	1.79e-05	0.000287	CbGpPWpGaD
Flutamide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	1.71e-05	0.000274	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—HPGDS—urinary bladder cancer	1.7e-05	0.000273	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ENO2—urinary bladder cancer	1.7e-05	0.000273	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.69e-05	0.000271	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GSTT1—urinary bladder cancer	1.65e-05	0.000265	CbGpPWpGaD
Flutamide—AR—Gene Expression—NCOR1—urinary bladder cancer	1.63e-05	0.000262	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.63e-05	0.000261	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	1.61e-05	0.000259	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	1.61e-05	0.000258	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—TYMP—urinary bladder cancer	1.53e-05	0.000246	CbGpPWpGaD
Flutamide—AR—Gene Expression—ERCC2—urinary bladder cancer	1.53e-05	0.000246	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	1.53e-05	0.000245	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NAT1—urinary bladder cancer	1.53e-05	0.000245	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	1.52e-05	0.000244	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	1.5e-05	0.000241	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	1.48e-05	0.000238	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.45e-05	0.000233	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—TYMP—urinary bladder cancer	1.45e-05	0.000232	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	1.4e-05	0.000224	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.39e-05	0.000223	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NAT2—urinary bladder cancer	1.39e-05	0.000223	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—MYC—urinary bladder cancer	1.38e-05	0.000222	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—NQO1—urinary bladder cancer	1.37e-05	0.00022	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.33e-05	0.000213	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NAT2—urinary bladder cancer	1.31e-05	0.00021	CbGpPWpGaD
Flutamide—AR—Gene Expression—ESR1—urinary bladder cancer	1.28e-05	0.000206	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	1.26e-05	0.000201	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	1.24e-05	0.000199	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—RRM2—urinary bladder cancer	1.2e-05	0.000192	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.19e-05	0.000191	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	1.19e-05	0.00019	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—TYMP—urinary bladder cancer	1.19e-05	0.00019	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.18e-05	0.000189	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.18e-05	0.000189	CbGpPWpGaD
Flutamide—AR—Gene Expression—PPARG—urinary bladder cancer	1.17e-05	0.000188	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.16e-05	0.000186	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	1.16e-05	0.000185	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GSTP1—urinary bladder cancer	1.14e-05	0.000183	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.14e-05	0.000183	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—RRM2—urinary bladder cancer	1.13e-05	0.000181	CbGpPWpGaD
Flutamide—AR—Gene Expression—CREBBP—urinary bladder cancer	1.12e-05	0.00018	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ENO2—urinary bladder cancer	1.11e-05	0.000178	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	1.11e-05	0.000178	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.11e-05	0.000178	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.08e-05	0.000173	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	1.08e-05	0.000173	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NAT2—urinary bladder cancer	1.07e-05	0.000172	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—TYMS—urinary bladder cancer	1.06e-05	0.000171	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—NCOR1—urinary bladder cancer	1.05e-05	0.000169	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GSTM1—urinary bladder cancer	1.05e-05	0.000169	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ENO2—urinary bladder cancer	1.05e-05	0.000168	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—HPGDS—urinary bladder cancer	1.05e-05	0.000168	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.04e-05	0.000167	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTT1—urinary bladder cancer	1.02e-05	0.000163	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GPX1—urinary bladder cancer	1.01e-05	0.000161	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1e-05	0.000161	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ERCC2—urinary bladder cancer	9.89e-06	0.000159	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	9.7e-06	0.000155	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—MTHFR—urinary bladder cancer	9.29e-06	0.000149	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	9.27e-06	0.000149	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—RRM2—urinary bladder cancer	9.26e-06	0.000148	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—TYMP—urinary bladder cancer	9.24e-06	0.000148	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	9.16e-06	0.000147	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NQO1—urinary bladder cancer	8.94e-06	0.000143	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	8.92e-06	0.000143	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	8.88e-06	0.000142	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	8.58e-06	0.000138	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ENO2—urinary bladder cancer	8.58e-06	0.000138	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.53e-06	0.000137	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NQO1—urinary bladder cancer	8.45e-06	0.000135	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NAT2—urinary bladder cancer	8.36e-06	0.000134	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	8.32e-06	0.000133	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.2e-06	0.000131	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.19e-06	0.000131	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PPARG—urinary bladder cancer	7.53e-06	0.000121	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	7.46e-06	0.00012	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CREBBP—urinary bladder cancer	7.24e-06	0.000116	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—RRM2—urinary bladder cancer	7.22e-06	0.000116	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.15e-06	0.000115	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—TYMP—urinary bladder cancer	7.13e-06	0.000114	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	7.05e-06	0.000113	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—TYMS—urinary bladder cancer	6.93e-06	0.000111	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NQO1—urinary bladder cancer	6.91e-06	0.000111	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	6.85e-06	0.00011	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	6.85e-06	0.00011	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.82e-06	0.000109	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.71e-06	0.000108	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	6.68e-06	0.000107	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ENO2—urinary bladder cancer	6.68e-06	0.000107	CbGpPWpGaD
Flutamide—AR—Gene Expression—MYC—urinary bladder cancer	6.67e-06	0.000107	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.64e-06	0.000107	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GPX1—urinary bladder cancer	6.56e-06	0.000105	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—TYMS—urinary bladder cancer	6.55e-06	0.000105	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	6.48e-06	0.000104	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	6.47e-06	0.000104	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	6.47e-06	0.000104	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NAT2—urinary bladder cancer	6.45e-06	0.000103	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	6.44e-06	0.000103	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.38e-06	0.000102	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GPX1—urinary bladder cancer	6.2e-06	9.94e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	6.09e-06	9.76e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	6.06e-06	9.71e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTGS2—urinary bladder cancer	5.93e-06	9.5e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.85e-06	9.38e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	5.77e-06	9.25e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	5.72e-06	9.18e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.58e-06	8.95e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—RRM2—urinary bladder cancer	5.57e-06	8.93e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NQO1—urinary bladder cancer	5.39e-06	8.64e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—TYMS—urinary bladder cancer	5.36e-06	8.6e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	5.3e-06	8.5e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	5.3e-06	8.5e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.23e-06	8.38e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTEN—urinary bladder cancer	5.17e-06	8.29e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ENO2—urinary bladder cancer	5.16e-06	8.27e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	5.16e-06	8.27e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GPX1—urinary bladder cancer	5.07e-06	8.14e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	5e-06	8.02e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	4.98e-06	7.99e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—EP300—urinary bladder cancer	4.93e-06	7.91e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PPARG—urinary bladder cancer	4.91e-06	7.88e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	4.72e-06	7.57e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	4.68e-06	7.51e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PPARG—urinary bladder cancer	4.64e-06	7.44e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.56e-06	7.31e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	4.49e-06	7.2e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	4.46e-06	7.15e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.35e-06	6.97e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—TYMS—urinary bladder cancer	4.18e-06	6.7e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NQO1—urinary bladder cancer	4.16e-06	6.67e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	4.13e-06	6.62e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	4.13e-06	6.62e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GPX1—urinary bladder cancer	3.95e-06	6.34e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	3.88e-06	6.22e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	3.86e-06	6.2e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PPARG—urinary bladder cancer	3.8e-06	6.09e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	3.65e-06	5.85e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	3.65e-06	5.85e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	3.65e-06	5.85e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	3.47e-06	5.56e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTEN—urinary bladder cancer	3.37e-06	5.4e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—TYMS—urinary bladder cancer	3.22e-06	5.17e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—EP300—urinary bladder cancer	3.21e-06	5.15e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	3.19e-06	5.11e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	3.19e-06	5.11e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTEN—urinary bladder cancer	3.18e-06	5.1e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GPX1—urinary bladder cancer	3.05e-06	4.89e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—EP300—urinary bladder cancer	3.04e-06	4.87e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	3e-06	4.8e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	2.99e-06	4.79e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PPARG—urinary bladder cancer	2.96e-06	4.74e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	2.84e-06	4.56e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	2.82e-06	4.52e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTEN—urinary bladder cancer	2.6e-06	4.18e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—EP300—urinary bladder cancer	2.48e-06	3.98e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	2.33e-06	3.73e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PPARG—urinary bladder cancer	2.28e-06	3.66e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	2.19e-06	3.52e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTEN—urinary bladder cancer	2.03e-06	3.25e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—EP300—urinary bladder cancer	1.94e-06	3.1e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.8e-06	2.88e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.57e-06	2.51e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.49e-06	2.4e-05	CbGpPWpGaD
